Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
about
Evaluation of mannitol salt agar for detection of oxacillin resistance in Staphylococcus aureus by disk diffusion and agar screeningInactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression.Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease.Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge.Microbiology of airway disease in patients with cystic fibrosis.Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria.Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosisAssessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaire.The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing To Predict mecA-Mediated Oxacillin Resistance in Atypical Staphylococcus aureus.Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples.Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation.Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureusOptimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus.Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles.
P2860
Q33675869-C4D1CFB5-3205-4661-BD45-54FBD02D9FD3Q34026284-E697A1F9-C03D-40DE-8C0A-02533ADC44BFQ34951284-BBE239BD-39BF-433A-A22A-3D8374F1C2B5Q35213050-AD93A34A-F8D6-44F8-AF5D-3E87ED15B7D5Q35690337-16B9D643-8452-4204-862D-1D615F30E490Q35807037-4751AA3C-BF92-4458-8F1D-0ADE7DF823EFQ36287704-6F37E723-192B-41EF-A408-24B17657E790Q36290528-51B2DD59-41E3-4AB3-B993-1D56C323A099Q36636914-3EE78A4D-FCCA-4CC1-9788-D6715A66E1B5Q36675223-BB9F0F61-5596-42DF-BDA6-A1C2097BE870Q36789284-10B431DE-9E11-4B69-8EF9-5134F5E99078Q36957900-B1F61822-0431-454D-9145-84395476C85FQ37463364-4D38E5C3-B56D-4469-AE3C-2A0559DE528CQ38323549-A5CA7E4C-F028-4F03-BB16-5A57664410E4Q38898519-DD7FF136-FB07-4C9C-95E9-4EE766D41696Q39141694-744CAD44-5327-4C9E-A4AD-234CCDBD66F5Q39352419-0D759431-7631-47F6-A573-BBFE069DD3F7Q39486100-899B6E0C-1540-4E73-9F54-04604B7D5E27Q39732905-1728DCF4-C422-44D4-B7CD-54B4B930A7D9Q40008470-613AC942-D5E2-4E88-987B-B753593C9A13Q40030687-7A4CE591-DF8E-4426-9C0B-45A9DBCABDAEQ40214870-46AFD8B1-92E8-405B-B4BE-7CF4BE1EA465Q41870463-BB21A1EF-37CB-4441-96AB-E3244EA88683Q41911383-D44B6C17-3739-42F0-8DF9-5FF8646A570CQ42587250-C83BFD96-502A-4AC4-8C6A-2B9FCACC7A6A
P2860
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
@en
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.
@nl
type
label
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
@en
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.
@nl
prefLabel
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
@en
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.
@nl
P2093
P2860
P1476
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
@en
P2093
P2860
P304
P407
P577
1987-07-01T00:00:00Z